190 related articles for article (PubMed ID: 38203624)
1. BAY-3827 and SBI-0206965: Potent AMPK Inhibitors That Paradoxically Increase Thr172 Phosphorylation.
Hawley SA; Russell FM; Ross FA; Hardie DG
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203624
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Paradoxical Activation of AMPK by the Kinase Inhibitors SU6656 and Sorafenib.
Ross FA; Hawley SA; Auciello FR; Gowans GJ; Atrih A; Lamont DJ; Hardie DG
Cell Chem Biol; 2017 Jul; 24(7):813-824.e4. PubMed ID: 28625738
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965.
Dite TA; Langendorf CG; Hoque A; Galic S; Rebello RJ; Ovens AJ; Lindqvist LM; Ngoei KRW; Ling NXY; Furic L; Kemp BE; Scott JW; Oakhill JS
J Biol Chem; 2018 Jun; 293(23):8874-8885. PubMed ID: 29695504
[TBL] [Abstract][Full Text] [Related]
4. AMP-Activated Protein Kinase: Do We Need Activators or Inhibitors to Treat or Prevent Cancer?
Russell FM; Hardie DG
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375416
[TBL] [Abstract][Full Text] [Related]
5. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade.
Sanders MJ; Grondin PO; Hegarty BD; Snowden MA; Carling D
Biochem J; 2007 Apr; 403(1):139-48. PubMed ID: 17147517
[TBL] [Abstract][Full Text] [Related]
6. Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells.
Xie Z; Dong Y; Zhang M; Cui MZ; Cohen RA; Riek U; Neumann D; Schlattner U; Zou MH
J Biol Chem; 2006 Mar; 281(10):6366-75. PubMed ID: 16407220
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the specificity and mechanism of action of the ULK1/AMPK inhibitor SBI-0206965.
Ahwazi D; Neopane K; Markby GR; Kopietz F; Ovens AJ; Dall M; Hassing AS; Gräsle P; Alshuweishi Y; Treebak JT; Salt IP; Göransson O; Zeqiraj E; Scott JW; Sakamoto K
Biochem J; 2021 Aug; 478(15):2977-2997. PubMed ID: 34259310
[TBL] [Abstract][Full Text] [Related]
8. AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2.
Fogarty S; Ross FA; Vara Ciruelos D; Gray A; Gowans GJ; Hardie DG
Mol Cancer Res; 2016 Aug; 14(8):683-95. PubMed ID: 27141100
[TBL] [Abstract][Full Text] [Related]
9. β-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK).
Oakhill JS; Chen ZP; Scott JW; Steel R; Castelli LA; Ling N; Macaulay SL; Kemp BE
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19237-41. PubMed ID: 20974912
[TBL] [Abstract][Full Text] [Related]
10. The Marine-Derived Macrolactone Mandelalide A Is an Indirect Activator of AMPK.
Mattos DR; Wan X; Serrill JD; Nguyen MH; Humphreys IR; Viollet B; Smith AB; McPhail KL; Ishmael JE
Mar Drugs; 2022 Jun; 20(7):. PubMed ID: 35877711
[TBL] [Abstract][Full Text] [Related]
11. Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus.
Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Menendez JA
Cell Cycle; 2011 Apr; 10(8):1295-302. PubMed ID: 21474997
[TBL] [Abstract][Full Text] [Related]
12. Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells.
Pang T; Zhang ZS; Gu M; Qiu BY; Yu LF; Cao PR; Shao W; Su MB; Li JY; Nan FJ; Li J
J Biol Chem; 2008 Jun; 283(23):16051-60. PubMed ID: 18321858
[TBL] [Abstract][Full Text] [Related]
13. Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662.
Ducommun S; Ford RJ; Bultot L; Deak M; Bertrand L; Kemp BE; Steinberg GR; Sakamoto K
Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E688-96. PubMed ID: 24425763
[TBL] [Abstract][Full Text] [Related]
14. Calmodulin-dependent protein kinase kinase-beta activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP.
Fogarty S; Hawley SA; Green KA; Saner N; Mustard KJ; Hardie DG
Biochem J; 2010 Jan; 426(1):109-18. PubMed ID: 19958286
[TBL] [Abstract][Full Text] [Related]
15. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
[TBL] [Abstract][Full Text] [Related]
16. The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis.
Vazquez-Martin A; Oliveras-Ferraros C; Menendez JA
Cell Cycle; 2009 Aug; 8(15):2385-98. PubMed ID: 19556893
[TBL] [Abstract][Full Text] [Related]
17. The ULK1/2 and AMPK Inhibitor SBI-0206965 Blocks AICAR and Insulin-Stimulated Glucose Transport.
Knudsen JR; Madsen AB; Persson KW; Henríquez-Olguín C; Li Z; Jensen TE
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231045
[TBL] [Abstract][Full Text] [Related]
18. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
Hawley SA; Boudeau J; Reid JL; Mustard KJ; Udd L; Mäkelä TP; Alessi DR; Hardie DG
J Biol; 2003; 2(4):28. PubMed ID: 14511394
[TBL] [Abstract][Full Text] [Related]
19. A subset of VEGFR-TKIs activates AMPK in LKB1-mutant lung cancer.
Yang L; Zhang Q; Xiong Y; Dang Z; Xiao H; Chen Q; Dai X; Zhang L; Zhu J; Wang D; Li M
Cancer Sci; 2023 Apr; 114(4):1651-1662. PubMed ID: 36459496
[TBL] [Abstract][Full Text] [Related]
20. Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome.
Hill JL; Kobori N; Zhao J; Rozas NS; Hylin MJ; Moore AN; Dash PK
J Neurochem; 2016 Oct; 139(1):106-19. PubMed ID: 27379837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
